AAAAAA

   
Results: 1-8 |
Results: 8
Selective tumor sensitization to taxanes with the MAB-drug conjugate CBR96-doxorubicin
Authors: Wahl, AF Donaldson, KL Mixan, BJ Trail, PA Siegall, CB
Citation: Af. Wahl et al., Selective tumor sensitization to taxanes with the MAB-drug conjugate CBR96-doxorubicin, INT J CANC, 93(4), 2001, pp. 590-600
Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291
Authors: Naglich, JG Jure-Kunkel, M Gupta, E Fargnoli, J Henderson, AJ Lewin, AC Talbott, R Baxter, A Bird, J Savopoulos, R Wills, R Kramer, RA Trail, PA
Citation: Jg. Naglich et al., Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291, CANCER RES, 61(23), 2001, pp. 8480-8485
Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model
Authors: Remsen, LG Trail, PA Hellstrom, I Hellstrom, KE Neuwelt, EA
Citation: Lg. Remsen et al., Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model, NEUROSURGER, 46(3), 2000, pp. 704-709
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells
Authors: Salih, HR Kosowski, SG Haluska, VF Starling, GC Loo, DT Lee, F Aruffo, AA Trail, PA Kiener, PA
Citation: Hr. Salih et al., Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells, J IMMUNOL, 165(5), 2000, pp. 2903-2910
Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin
Authors: Trail, PA Willner, D Bianchi, AB Henderson, AJ TrailSmith, MD Girit, E Lasch, S Hellstrom, I Hellstrom, KE
Citation: Pa. Trail et al., Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin, CLIN CANC R, 5(11), 1999, pp. 3632-3638
Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates
Authors: King, HD Yurgaitis, D Willner, D Firestone, RA Yang, MB Lasch, SJ Hellstrom, KE Trail, PA
Citation: Hd. King et al., Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates, BIOCONJ CHE, 10(2), 1999, pp. 279-288
Monoclonal antibody drug conjugates in the treatment of cancer
Authors: Trail, PA Bianchi, AB
Citation: Pa. Trail et Ab. Bianchi, Monoclonal antibody drug conjugates in the treatment of cancer, CURR OP IM, 11(5), 1999, pp. 584-588
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis
Authors: Ji, WDR Castellino, FJ Chang, Y Deford, ME Gray, H Villarreal, X Kondri, ME Marti, DN Llinas, M Schaller, J Kramer, RA Trail, PA
Citation: Wdr. Ji et al., Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis, FASEB J, 12(15), 1998, pp. 1731-1738
Risultati: 1-8 |